SOCIAL SIGNIFICANCE OF FAMILIAL HYPERCHOLESTEROLEMIA
Journal Title: Българско списание за обществено здраве (Bulgarian Journal of Public Health) - Year 2018, Vol 0, Issue 4
Abstract
Cardiovascular diseases are the most common debilitating condition worldwide. In the European Union, ischemic heart disease (a type of CVD due to atherosclerosis) remains the most common cause of death, causing approximately 1.8 million deaths (20% of all deaths) per year in Europe. Elevated LDL-C, the main component of total cholesterol, plays an important role in the development of atherosclerotic plaques and is the major cause of increased CV risk. Large-scale epidemiological studies have shown that elevated LDL-C levels are a major mechanism of the cardiovascular (CV) risk, demonstrating a direct connection between LDL-C levels and the incidence of a newly emerged IHD and IHD-related events, including death. FH is a hereditary disease caused by a variety of genetic mutations leading to significantly elevated LDL-C levels and resulting in 20-times higher lifelong risk of a premature CVD. Patients with FH may have several symptoms and risk factors, including family history of premature IHD, presence of early IHD as a separate case; elevated LDL-C levels; tendon xanthomas (cholesterol-rich deposits in the tendons of the hands, feet and heels); and corneal arc (lipid deposits on the cornea). There are 2 genetic options of FH: one is caused by the inheritance of the FH gene from one of the parents (HeFH) and the other is caused by the inheritance of the gene from the two parents (HoFH). HoFH is an extremely rare disease affecting approximately 1 in 1 million people worldwide and is therefore considered an extremely rare indication (orphan). By contrast, the calculated HeFH prevalence is 1 in 500 people worldwide. In patients with untreated FH, the risk of premature IHD is about 20 times higher. Untreated male patients have a 50% risk of a coronary event up to 50 years of age; untreated women have a 30% risk of a coronary event up to 60 years of age. As a result, FH patients need the most intense lipid-modifying treatment that they can tolerate in reasonable limits.
Authors and Affiliations
Svetoslav Tsenov, Evgeni Grigorov, Plamen Dimitrov
Keywords
Related Articles
- EP ID EP461407
- DOI -
- Views 66
- Downloads 0
RESEARCH OF THE CITIZENS’ATTITUDE IN THEIR USE OF PLANT FOOD SUPPLEMENTS IN BULGARIA
This publication presents the results of a research into consumers’ attitudes towards the use of teas. Materials and methods: A cross-sectional survey design with 400 individuals aged 18-80, who expressed willingness and...
THERAPEUTIC AND PREVENTIVE STRATEGIES IN ACUTE CORONARY SYNDROME IN OLDER PEOPLE
The aim of this review is to summarize published materials from various sources on the preventive and therapeutic strategies for acute coronary syndrome (ACS) in adults by using methods of collecting, processing, analyzi...
BASIC PRINCIPLES IN QUALITY ASSURANCE AND CONTROL OF RESULTS OF FOOD CHEMICAL ANALYSES
Provision and quality control of the results of chemical analyzes of foods are important prerequisites for obtaining objective data from chemical analysis. The article provides an overview of standards and guidelines for...
KEY ASPECTS OF NUTRITION AND DIETARY GUIDELINES FOR NEUROLOGICALLY IMPAIRED AND MENTALLY RETARDED CHILDREN
Children with neurological disorders and mental retardation are at risk for complications in nutrition and nutritional status, which calls for special care and attention on children’s diets both by medical staff and pare...
INTENSIFICATION OF TRANS-BORDER COOPERATION - FROM PRIMARY CARE TO EMERGENCY CARE
Cross-border cooperation between the Rhodope Region, Northern Greece and Kardzhali Region, Bulgaria dates back as far as over ten years, with actual achievements of several successfully completed projects. A major role i...